Deprecated: abs(): Passing null to parameter #1 ($num) of type int|float is deprecated in /home/individends/public_html/financial_analysis.php on line 303

Profitability Metrics

Gross Margin
86.73%
Operating Margin
85.47%
Net Margin
38.77%

Efficiency Metrics

Revenue per Expense Ratio
6.88
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
-45.26%
Income Tax Rate
0.00%
EPS
0.2800000000

Balance Sheet Analysis

Current Ratio
955.81
Cash Ratio
92.83
Working Capital
$2.18M
Debt to Equity
0.01
Debt to Assets
0.62%
Equity Ratio
99.13%

Cash Flow Analysis

Operating Cash Flow Ratio
0.00%
Free Cash Flow Ratio
0.00%
CapEx to Revenue
0.00%
Dividends Paid
No dividends paid
Stock Buybacks
No buybacks
Total Shareholder Returns
No shareholder returns
Cash Position Change
66.32%

Key Takeaways (2023 FY)

  • Maintained positive net income growth despite revenue changes
  • Increased R&D investment by 100.00%

Detailed Growth Metrics

Core Performance

Revenue
167.93%
Net Income
126.10%
EPS
113.21%
Operating Income
157.61%

Operational Efficiency

R&D Expenses
100.00%
SG&A Expenses
423.06%
Operating Cash Flow
0.00%
Free Cash Flow
0.00%

Balance Sheet Health

Assets
96.50%
Debt
0.00%
Book Value per Share
-1.45%
Inventory
-100.00%

Shareholder Returns

Dividends per Share
0.00%
Shares Outstanding
98.14%

Long Term Trends

3Y Revenue/Share
502.78%
5Y Revenue/Share
316.03%
3Y Dividend/Share
0.00%
5Y Dividend/Share
0.00%